[1] Ohfuji S, Takagi A, Nakano T, Kumihashi H, Kano M, Tanaka T. Mumps-related disease burden in Japan: analysis of JMDC health insurance reimbursement data for 2005-2017. J Epidemiol 2021;31(8):464 − 70. https://doi.org/10.2188/jea.JE20200048.
[2] Li P, Wang FZ, Yang H, Huang AD, Ma C, Yin ZD. Epidemiological characteristics and spatial-temporal clustering of mumps in China, 2004-2021. Chin J Vaccines Immun 2023;29(1):19 − 24. https://doi.org/10.19914/j.CJVI.2023004.
[3] Li D, Zhang HR, You N, Chen ZF, Yang XH, Zhang HS, et al. Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China. Hum Vaccin Immunother 2022;18(6):2096375. https://doi.org/10.1080/21645515.2022.2096375.
[4] Sun X, Tang FY, Hu Y, Deng XY, Wang ZG, Zhou MH, et al. High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China. Hum Vaccin Immunother 2020;16(7):1738 − 42. https://doi.org/10.1080/21645515.2019.1708162.
[5] Yin ZY, Wen TC, Fang QJ, Zheng CJ, Gong XY, Li JJ, et al. Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China. Hum Vaccin Immunother 2022;18(5):2086774. https://doi.org/10.1080/21645515.2022.2086774.
[6] Wu RH, Chen ZF, Yang XH, Chen YH, Chen DH, Zhang HR, et al. Investigating the characteristics of mumps outbreaks in Fujian Province, China. Vaccine 2024;42(26):126415. https://doi.org/10.1016/j.vaccine.2024.126415.
[7] Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi DL, et al. Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open Forum Infect Dis 2014;1(3):ofu094. https://doi.org/10.1093/ofid/ofu094.
[8] Sarawanangkoor N, Wanlapakorn N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y. Persistence of antibodies against measles, mumps, and rubella after the two-dose MMR vaccination: a 7-year follow-up study. Vaccines 2024;12(7):744. https://doi.org/10.3390/vaccines12070744.
[9] Rasheed MAU, Hickman CJ, McGrew M, Sowers SB, Mercader S, Hopkins A, et al. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood. Proc Natl Acad Sci USA 2019;116(38):19071 − 6. https://doi.org/10.1073/pnas.1905570116.
[10] Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature 1985;318(6044):323 − 9. https://doi.org/10.1038/318323a0.
[11] Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012;367(18):1704 − 13. https://doi.org/10.1056/NEJMoa1202865.
[12] Qin W, Wang Y, Yang T, Xu XK, Meng XM, Zhao CJ, et al. Outbreak of mumps in a student population with high vaccination coverage in China: time for two-dose vaccination. Hum Vaccin Immunother 2019;15(9):2106 − 11. https://doi.org/10.1080/21645515.2019.1581526.
[13] Wang DN, Nie TY, Pan F, Wang Y, Wang J, Qin W. Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China. Hum Vaccin Immunother 2021;17(7):2072 − 7. https://doi.org/10.1080/21645515.2020.1861877.
[14] Zhang C, Shen JY, Luo XF, Han LP. Epidemiological characteristics of breakthrough cases of breakthrough mumps cases among children under eighteen years old between 2017 and 2021 in Huzhou City. China Modern Doctor 2023;61(26):70 − 3,78. https://doi.org/10.3969/j.issn.1673-9701.2023.26.014.
[15] Cardemil CV, Dahl RM, James L, Wannemuehler K, Gary HE, Shah M, et al. Effectiveness of a third dose of MMR vaccine for mumps outbreak control. N Engl J Med 2017;377(10):947 − 56. https://doi.org/10.1056/NEJMoa1703309.